The Delisting Survival Guide: What Separates Survivors From Statistics
In 2023, NASDAQ issued over 1,200 deficiency notices. Roughly half of those companies regained compliance. The divergence starts with how quickly and credibly management responds — not with underlying business fundamentals.
Common Deficiency Triggers
- •Minimum bid price below $1.00 for 30 consecutive trading days
- •Stockholders' equity below $2.5M (NASDAQ) or $4M (NYSE American)
- •Non-timely filing of 10-K or 10-Q
- •Market value of listed securities falling below thresholds
Each deficiency has different cure windows and procedural paths.
The Filing Problem Nobody Talks About
Non-timely filing deficiencies are the most preventable and most damaging. When you miss a deadline, it signals accounting complexity, auditor disputes, or operational dysfunction. Algorithms flag your stock before the exchange formally notifies you.
The IR response should begin before the deadline is missed — proactive communication, Form NT filed on time, public statement explaining the delay.
Survival Playbook: First 30 Days
Day 1–3: Confirm the exact standard violated and cure deadline. Retain securities counsel. Brief the board.
Day 4–7: Assess all cure paths. For minimum bid price, understand the algo signals a reverse split generates before committing.
Day 8–14: Prepare the formal compliance plan with specific milestones. A vague plan signals management doesn't have a path.
Day 15–30: Controlled communications strategy. Major shareholders hear from management directly, before media coverage, with specifics.
What Institutional Holders Watch
Companies that retain support during deficiency share these traits: management communicates proactively, the compliance plan is filed early, and there is a clear financial event addressing the underlying trigger.
The OTC Cliff
OTC stocks lose roughly 40% of institutional ownership within 90 days of delisting. The liquidity profile changes permanently.
Prevention is categorically cheaper than recovery. Get your free algo score to understand your current risk profile before any deficiency notice arrives.
IR Intelligence Weekly
Data-driven insights on SEC filings, algo signals, and small-cap IR strategy. Read by 500+ CEOs and CFOs. No spam, unsubscribe anytime.
Join 500+ public company executives. Weekly delivery, no fluff.
See Your Company's Algo Score
Free analysis of your latest SEC filing. No account required.
Analyze My Ticker Free